Intensive Care Medicine Experimental is a premier open-access journal dedicated to advancing research and clinical practice within the realms of critical care, intensive care medicine, and emergency medicine. Published by SPRINGER, this influential journal has been committed to dispensing high-quality, peer-reviewed research since its inception in 2013, reflecting its progressive approach to open-access publishing and enhancing global accessibility to vital medical information. With a notable impact factor and categorically established Q1 rankings in both Critical Care and Emergency Medicine, as well as Q2 in Physiology (medical), the journal underscores its significance in disseminating groundbreaking studies and innovations. Positioned prominently within the medical literature, Intensive Care Medicine Experimental ranks 16th in Emergency Medicine and 27th in Critical Care, providing a vital platform for researchers, clinicians, and students alike to explore and share cutting-edge research findings that aim to improve patient outcomes. The journal's dedication to fostering collaboration and dialogue among professionals makes it an essential resource in the evolving landscape of intensive care and emergency medical disciplines.

JOURNAL OF BIOMATERIALS APPLICATIONS, published by SAGE PUBLICATIONS LTD, serves as a pivotal platform for the dissemination of cutting-edge research in the field of biomaterials and biomedical engineering. With an ISSN of 0885-3282 and an E-ISSN of 1530-8022, this journal has been a respected venue for scholarly communication since its inception in 1986. Aiming to provide comprehensive insights into the applications of biomaterials, this journal publishes high-quality articles that explore innovative materials and methodologies, thereby fostering advancements in medical technology and tissue engineering. The journal consistently ranks in the third quartile (Q3) for both Biomaterials and Biomedical Engineering categories, strengthening its position among the noteworthy academic resources available today. With a dedicated readership comprising researchers, industry professionals, and students, JOURNAL OF BIOMATERIALS APPLICATIONS plays a vital role in supporting knowledge exchange and scientific progress within these dynamic fields.

THERAPEUTIC APHERESIS AND DIALYSIS is an esteemed journal published by Wiley, focusing on the fields of hematology and nephrology. Since its inception in 2003, the journal has provided a dedicated platform for research and advancements in therapeutic apheresis and dialysis methodologies, offering valuable insights for clinicians and researchers alike. With an ISSN of 1744-9979 and an E-ISSN of 1744-9987, the journal has established itself within Q3 in both the hematology and nephrology categories. Its Scopus rankings place it at #44 in nephrology and #79 in hematology, indicating its growing influence in these critical areas of medical research. Although it does not currently offer open access, THERAPEUTIC APHERESIS AND DIALYSIS remains a vital resource for professionals aiming to stay at the forefront of innovations and practices through 2024 and beyond. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and discussions presented within its pages, solidifying its role in enhancing patient care and therapeutic strategies.

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of biomedical materials science. With an ISSN of 0957-4530 and E-ISSN 1573-4838, this Open Access journal has been committed to providing researchers and professionals with freely accessible, high-quality research since 2021. It features an extensive scope spanning bioengineering, biomaterials, biomedical engineering, and biophysics, reflecting its significant impact within these interdisciplinary domains. Recognized within the Q2 category of the 2023 rankings in multiple fields, the journal proudly positions itself as a crucial resource for innovative materials that contribute to advancements in medical applications. With impressive Scopus rankings, including 26th in Biophysics and 40th in Materials Science for Biomaterials, researchers, students, and industry professionals alike can rely on this publication for cutting-edge insights that drive the future of medical materials and technologies. Based in Dordrecht, Netherlands, the journal provides a vibrant platform for sharing groundbreaking discoveries and fostering collaborative research among a global audience.

TECHNOLOGY AND HEALTH CARE, published by IOS PRESS, stands as a prominent interdisciplinary journal dedicated to the integration of technology within the healthcare sector. With an ISSN of 0928-7329 and an E-ISSN of 1878-7401, this journal has been a vital resource since its inception in 1993, providing insights and advancements in various categories including bioengineering, biomedical engineering, health informatics, and more. Though it currently holds a Q4 classification in several fields and Q3 in others, it actively contributes to the dialogue surrounding innovative methodologies and practices that enhance healthcare delivery. Researchers, professionals, and students will find the journal invaluable for its diverse range of studies that explore the convergence of technology and health. Its commitment to fostering impactful research continues to reinforce its relevance in the evolving landscape of healthcare technology.

Bioengineering-Basel, an esteemed journal published by MDPI, stands at the forefront of innovation in the field of bioengineering since its inception in 2014. With an E-ISSN of 2306-5354, this fully Open Access journal based in Switzerland provides a platform for researchers and professionals to disseminate cutting-edge findings across various aspects of bioengineering, including biomaterials, tissue engineering, and biopharmaceuticals. The journal has been recognized with a Q3 ranking in the 2023 Bioengineering category, reflecting its commitment to quality and relevance. By facilitating widespread accessibility to academic knowledge, Bioengineering-Basel aims to foster collaboration and stimulate thought leadership within the global research community, making it an indispensable resource for students, scholars, and industry practitioners alike.

Current Opinion in Biomedical Engineering is a renowned journal published by Elsevier, focusing on the cutting-edge developments and critical assessments in the fields of biomedical engineering and related disciplines. With an ISSN of 2468-4511, it provides a valuable platform for researchers and professionals to disseminate their insights and discoveries in areas such as bioengineering, biomaterials, and medicine. Its impressive impact factor positions it in the Q2 category for several fields, including Bioengineering and Biomedical Engineering, highlighting its influence and relevance in ongoing scientific dialogues. The journal’s unique format of opinion pieces and reviews encourages innovative thinking and fosters collaboration among experts. As an essential resource for those engaged in the life sciences and engineering, Current Opinion in Biomedical Engineering serves to stimulate discussion, promote knowledge exchange, and drive advancements in biomedical applications. Set in the Netherlands at Radarweg 29, 1043 NX Amsterdam, the journal is accessible through various academic platforms, enabling a global readership to engage with the latest scholarly work in this dynamic field.

AIMS Bioengineering, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing knowledge in the interdisciplinary field of bioengineering. With the ISSN 2375-1495, this journal has been providing a platform for the rapid dissemination of high-quality research since its establishment in 2014. AIMS Bioengineering covers a wide range of topics, including but not limited to, biomaterials, computational biology, and bioinformatics, making it an essential resource for researchers, professionals, and students alike. Although the H-index and specific category quartiles are not currently available, the journal's commitment to open access ensures that cutting-edge findings are accessible to a global audience, fostering collaboration and innovation in bioengineering. With its rigorous peer-review process and dedication to scholarly excellence, AIMS Bioengineering continues to play a pivotal role in shaping the future of the bioengineering landscape.

Acta of Bioengineering and Biomechanics is a distinguished academic journal published by Wroclaw University of Technology, Faculty of Computer Science & Management, focusing on the interdisciplinary fields of bioengineering and biomechanics. Since its inception in 2005, the journal has provided a platform for innovative research and critical reviews that contribute to the advancement of knowledge in areas such as biomaterials, biomedical engineering, and biophysics. Despite its current Q4 ranking in several categories, including Bioengineering and Biomaterials, it serves as a valuable resource for emerging scholars and seasoned professionals alike, highlighting the evolving landscape of research in these dynamic fields. The journal brings together a diverse range of studies, fostering collaboration and creativity among its readership. With its commitment to disseminating high-quality research, Acta of Bioengineering and Biomechanics plays an essential role in nurturing academic inquiry and professional growth within the scientific community in Poland and beyond.

Bioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.